(Q36614005)

15 August 2017

1 reference

title

Recent improvements in the detection and treatment of nonmuscle-invasive bladder cancer (English)

1 reference

15 August 2017

Ingo Kausch

1

1 reference

15 August 2017

Christian Doehn

series ordinal

2

1 reference

15 August 2017

Dieter Jocham

series ordinal

3

1 reference

15 August 2017

publication date

1 September 2006

1 reference

Expert Review of Anticancer Therapy

15 August 2017

published in

1 reference

15 August 2017

volume

6

1 reference

15 August 2017

issue

9

1 reference

15 August 2017

page(s)

1301-1311

1 reference

15 August 2017

cites work

Cancer statistics, 2005

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1301

Low-grade Ta (noninvasive) urothelial carcinoma of the bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1301

A systematic review of intravesical bacillus Calmette-Guérin plus transurethral resection vs transurethral resection alone in Ta and T1 bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1301

Bladder cancer. I. Molecular and genetic basis of carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1301

Mechanisms of Disease: genetic and epigenetic alterations that drive bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1301

Bladder cancer: epidemiology, staging and grading, and diagnosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1301

Fluorescence cystoscopy in the management of bladder cancer: a help for the urologist!

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1301

Cell-type specific protoporphyrin IX metabolism in human bladder cancer in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1301

Clinically relevant improvement of recurrence-free survival with 5-aminolevulinic acid induced fluorescence diagnosis in patients with superficial bladder tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1301

Improved detection and treatment of bladder cancer using hexaminolevulinate imaging: a prospective, phase III multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1301

Long-term benefit of 5-aminolevulinic acid fluorescence assisted transurethral resection of superficial bladder cancer: 5-year results of a prospective randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1301

Hypericin-based fluorescence diagnosis of bladder carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1301

Bladder cancer. II. Molecular aspects and diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1301

Urine markers for bladder cancer surveillance: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1301

Prognostic markers for bladder cancer: International Consensus Panel on bladder tumor markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1301

Identifying distinct classes of bladder carcinoma using microarrays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1301

High-grade Ta urothelial carcinoma and carcinoma in situ of the bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1301

Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1301

Immune mechanisms in bacillus Calmette-Guerin immunotherapy for superficial bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1301

A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1301

Bacillus calmette-guerin versus chemotherapy for the intravesical treatment of patients with carcinoma in situ of the bladder: a meta-analysis of the published results of randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1301

Intravesical bacillus Calmette-Guérin is superior to mitomycin C in reducing tumour recurrence in high-risk superficial bladder cancer: a meta-analysis of randomized trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1301

Intravesical bacillus Calmette-Guerin versus mitomycin C for superficial bladder cancer: a formal meta-analysis of comparative studies on recurrence and toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1301

Intravesical bacille Calmette-Guérin versus mitomycin C in superficial bladder cancer: formal meta-analysis of comparative studies on tumor progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1301

Bacillus Calmette-Guerin versus epirubicin for primary, secondary or concurrent carcinoma in situ of the bladder: results of a European Organization for the Research and Treatment of Cancer--Genito-Urinary Group Phase III Trial (30906).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1301

Tumor progression and survival in patients with T1G3 bladder tumors: multicentric retrospective study comparing 94 patients treated during 17 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1301

A randomized trial of intravesical doxorubicin and immunotherapy with bacille Calmette-Guérin for transitional-cell carcinoma of the bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1301

Recurrence, progression and survival in bladder cancer. A retrospective analysis of 232 patients with greater than or equal to 5-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1301

TUR and adjuvant intravesical chemotherapy in T1G3 bladder tumors: recurrence, progression and survival in 137 selected patients followed up to 20 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1301

A comparison of direct and liposomal antibody conjugates of sulfonated aluminum phthalocyanines for selective photoimmunotherapy of human bladder carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1301

Electromotive diffusion (EMD) and photodynamic therapy with delta-aminolaevulinic acid (delta-ALA) for superficial bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1301

Whole bladder photodynamic therapy with 5-aminolevulinic acid using a white light source

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1301

Comparison of aminolevulinic acid and hexylester aminolevulinate induced protoporphyrin IX distribution in human bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1301

Hypericin as a potential phototherapeutic agent in superficial transitional cell carcinoma of the bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1301

A phase-1 study of sequential mitomycin C and 5-aminolaevulinic acid-mediated photodynamic therapy in recurrent superficial bladder carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1301

Advances in gene therapy for bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1301

The p53 tumor suppressor gene and nuclear protein: basic science review and relevance in the management of bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1301

Repeated intravesical instillations of an adenoviral vector in patients with locally advanced bladder cancer: a phase I study of p53 gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1301

Evaluation of gene transfer efficiency by viral vectors to murine bladder epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1301

Human urinary bladder carcinomas express adenovirus attachment and internalization receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1301

Antisense oligonucleotides in the treatment of bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1301

Multicentric Study Comparing Intravesical Chemotherapy Alone and With Local Microwave Hyperthermia for Prophylaxis of Recurrence of Superficial Transitional Cell Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1301

Ablation of superficial bladder tumors with focused extracorporeal pyrotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1301

Electromotive drug administration and hydrodistention for the treatment of interstitial cystitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1301

Preliminary European Results of Local Microwave Hyperthermia and Chemotherapy Treatment in Intermediate or High Risk Superficial Transitional Cell Carcinoma of the Bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1301

Intravesical Bacillus Calmette-Guérin versus mitomycin C for Ta and T1 bladder cancer

21 January 2018

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1002/14651858.CD003231

Identifiers

DOI

10.1586/14737140.6.9.1301

1 reference

15 August 2017

1 reference